Michael S Aboodi
Overview
Explore the profile of Michael S Aboodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ware L, Files D, Fowler A, Aboodi M, Aggarwal N, Brower R, et al.
JAMA
. 2024 May;
332(5):390-400.
PMID: 38762798
Importance: Acetaminophen (paracetamol) has many pharmacological effects that might be beneficial in sepsis, including inhibition of cell-free hemoglobin-induced oxidation of lipids and other substrates. Objective: To determine whether acetaminophen increases...
2.
Thakkar J, Chand S, Aboodi M, Gone A, Alahiri E, Schecter D, et al.
Kidney360
. 2022 Apr;
1(12):1339-1344.
PMID: 35372894
Background: AKI has been reported in patients with COVID-19 pneumonia and it is associated with higher mortality. The aim of our study is to describe characteristics, outcomes, and 60-day hospital...
3.
Douin D, Ward M, Lindsell C, Howell M, Hough C, Exline M, et al.
Crit Care Explor
. 2021 Mar;
3(3):e0361.
PMID: 33786437
Objectives: Given finite ICU bed capacity, knowledge of ICU bed utilization during the coronavirus disease 2019 pandemic is critical to ensure future strategies for resource allocation and utilization. We sought...
4.
Siegel R, Ostfeld R, Aboodi M, Vittorio T, Mehlman Y, Travin M
J Cardiovasc Med (Hagerstown)
. 2021 Feb;
22(4):279-284.
PMID: 33633043
Aims: Although obesity is associated with increased mortality, epidemiologic studies in heart failure have reported lower mortality in obese patients compared with matched nonobese patients (the 'obesity paradox'). However, the...
5.
Self W, Tenforde M, Stubblefield W, Feldstein L, Steingrub J, Shapiro N, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Nov;
69(47):1762-1766.
PMID: 33237893
Most persons infected with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), develop virus-specific antibodies within several weeks, but antibody titers might decline over time. Understanding the timeline of...
6.
Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski D, et al.
J Intensive Care Med
. 2020 Oct;
36(12):1483-1490.
PMID: 33021131
Background: Covid-19 associated coagulopathy (CAC) is associated with prothrombotic state and thromboembolism. However, true incidence of thromboembolic events is difficult to determine in the ICU setting. The aim of our...
7.
Self W, Tenforde M, Stubblefield W, Feldstein L, Steingrub J, Shapiro N, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Sep;
69(35):1221-1226.
PMID: 32881855
Health care personnel (HCP) caring for patients with coronavirus disease 2019 (COVID-19) might be at high risk for contracting SARS-CoV-2, the virus that causes COVID-19. Understanding the prevalence of and...
8.
Tenforde M, Kim S, Lindsell C, Rose E, Shapiro N, Files D, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Jul;
69(30):993-998.
PMID: 32730238
Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 (COVID-19). Characterizing return to baseline health among outpatients with milder COVID-19 illness is important for...
9.
Tenforde M, Rose E, Lindsell C, Shapiro N, Files D, Gibbs K, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Jul;
69(26):841-846.
PMID: 32614810
Descriptions of coronavirus disease 2019 (COVID-19) in the United States have focused primarily on hospitalized patients. Reports documenting exposures to SARS-CoV-2, the virus that causes COVID-19, have generally been described...
10.
Kwasiborski P, Czerwinski W, Kowalczyk P, Buksinska-Lisik M, Horszczaruk G, Aboodi M, et al.
Int J Cardiol
. 2020 Jun;
317:13-17.
PMID: 32504716
Background: Functional lesion assessment in stable coronary disease is considered the gold standard. The result of fractional flow reserve (FFR) in stable coronary disease is often a decision-maker for patient...